Interspecies variability of TNP-470 metabolism, using primary monkey, rat, and dog cultured hepatocytes

L Placidi1, E C Scott, G de Sousa

  • 1Department of Pharmacology and Toxicology, University of Alabama at Birmingham 35294-0019, USA.

Insights

The metabolism of TNP-470, an angiogenesis inhibitor, was studied in various animal species. Monkey metabolism closely resembles human biotransformation, with M-II as the predominant metabolite across species.

Area of Science:

  • Pharmacology
  • Drug Metabolism
  • Biochemistry

Background:

  • TNP-470 (O-(chloroacetylcarbamoyl)fumagillol; AGM 1470) is a potent in vitro inhibitor of angiogenesis.
  • Previous studies in human hepatocytes identified key metabolic pathways for TNP-470.

Purpose of the Study:

  • To investigate the biotransformation of TNP-470 in primary cultured hepatocytes and microsomal fractions from different species (monkey, dog, rat).
  • To compare the metabolic profiles of TNP-470 across species and with human metabolism.

Main Methods:

  • Primary cultured hepatocytes from monkey, dog, and rat were used.
  • Microsomal fractions from various monkey tissues (liver, intestine, kidney, lung) were analyzed.
  • Metabolites were identified and quantified, including M-I through M-VI.

Main Results:

  • The predominant extracellular metabolite in all species studied was M-II.
  • Monkey TNP-470 metabolism showed similarities to human metabolism, producing six derivatives (M-I to M-VI).
  • Metabolite M-VI was not detected in dog or rat hepatocytes; M-III was only found in liver samples.

Conclusions:

  • The metabolism of TNP-470 in monkeys is most closely related to that observed in humans.
  • While quantitative metabolic profiles varied between species, M-II is a consistent major metabolite.
  • Understanding interspecies metabolic differences is crucial for preclinical drug development.

Related Concept Videos